Fingerprint
Dive into the research topics of 'Rituximab: Current status as therapy for malignant and Benign hematologic disorders'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rituximab: Current status as therapy for malignant and Benign hematologic disorders
Nihal E. Abdulla, Mary J. Ninan, Avi B. Markowitz
Research output: Contribution to journal › Review article › peer-review
14
Scopus
citations